Analysts at TD Securities downgraded Valeant Pharmaceuticals International, Inc. (VRX) from ‘Buy’ to ‘Hold’ in a research report issued to clients on Monday. The cut comes after the company announced that it would be postponing its earnings report, which was originally scheduled for this morning. On valuation measures, Valeant Pharmaceuticals International Inc. stock it’s trading […]
View the full post at: Notable Downgrades: Valeant (VRX), Equinix (EQIX), SanDisk (SNDK), General Motors (GM), Nucor (NUE)